Facts of Tasigna (Nilotinib)
Product: Tasigna® (nilotinib) Capsules
indication: blood cancer (chronic myelogenous leukemia-CML)
Strength: 200 mg hard capsules
Company: Novartis Pharmaceuticals Corporation
South Delhi Pharma can facilitate patients and physicians access to commercially approved medicines, “Tasigna (Nilotinib) ” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Tasigna (Nilotinib) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
What Tasigna is?
Tasigna is a kinase inhibitor indicated for the treatment of chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (CML) in adult patients resistant to or intolerant to prior therapy that included imatinib.
What Nilotinib is?
Nilotinib, sold under the brand name Tasigna, is a medication used to treat chronic myelogenous leukemia (CML) which has the Philadelphia chromosome. It may be used both in initial cases of chronic phase CML as well as in accelerated and chronic phase CML that has not responded to imatinib. Nilotinib was approved for medical use in the United States in 2007. It is on the World Health Organization's List of Essential Medicines.